Orange Book product · Brand (NDA)
DIUPRES-250
CHLOROTHIAZIDE; RESERPINE
At a glance
Aug 26, 1987
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 26, 1987
39 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CHLOROTHIAZIDE; RESERPINE
Strength
250MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 011635
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1983CHLOROTHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088557 · HIKMA
- 1983CHLOROTHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088365 · HIKMA
- 1983CHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 088151 · WATSON LABS
- 1982CHLOROTHIAZIDE-RESERPINEGeneric (ANDA)
ANDA 087744 · PHARMOBEDIENT
- 1982CHLOROTHIAZIDE-RESERPINEGeneric (ANDA)
ANDA 087745 · PHARMOBEDIENT
- —CHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 084853 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
